SGLT2 inhibitors have clear protective effects against heart failure and chronic kidney disease, while GLP-1 receptor agonists can reduce the risk of heart attack, stroke, and also kidney disease - as recently demonstrated in the landmark FLOW trial, Neuen concluded
In this article, well explore their differences, effectiveness, and their role in weight loss
I always felt informed and supported
Standard injectable dose: 1-2mg daily Range: 0.5mg to 4mg depending on goals and experience Frequency: Once daily or split into morning and evening doses Cycle: 30 days on, 14 days off (standard) or 8 weeks on, 4 weeks off (intensive) Calculate your exact injection volume using the peptide calculator based on your reconstitution concentration
And I have a 1/2ml insulin pin so with that each small tick is 10mcg's